Equities research analysts expect CVS Health Corp (NYSE:CVS) to report $1.69 earnings per share (EPS) for the current quarter, Zacks reports. Twenty Three analysts have made estimates for CVS Health’s earnings, with the highest EPS estimate coming in at $1.71 and the lowest estimate coming in at $1.62. CVS Health also reported earnings per share of $1.69 during the same quarter last year. The firm is scheduled to issue its next earnings report on Wednesday, August 14th.

According to Zacks, analysts expect that CVS Health will report full-year earnings of $6.85 per share for the current fiscal year, with EPS estimates ranging from $6.75 to $7.15. For the next financial year, analysts forecast that the business will report earnings of $7.14 per share, with EPS estimates ranging from $6.85 to $7.51. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research firms that that provide coverage for CVS Health.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.50 by $0.12. The firm had revenue of $61.65 billion for the quarter, compared to analysts’ expectations of $60.39 billion. CVS Health had a positive return on equity of 16.80% and a negative net margin of 0.08%. The company’s revenue was up 34.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.48 EPS.

CVS has been the topic of several research analyst reports. SunTrust Banks lowered their price target on CVS Health from $85.00 to $65.00 in a report on Wednesday, April 10th. Bank of America reissued a “buy” rating and set a $74.00 price target (down from $82.00) on shares of CVS Health in a report on Wednesday, April 10th. Morgan Stanley set a $92.00 price target on CVS Health and gave the company a “buy” rating in a report on Friday, February 22nd. UBS Group lowered their price target on CVS Health from $75.00 to $74.00 and set a “buy” rating on the stock in a report on Thursday, February 21st. Finally, Citigroup lowered their price target on CVS Health from $94.00 to $68.00 and set a “buy” rating on the stock in a report on Wednesday, March 6th. Two analysts have rated the stock with a sell rating, seven have given a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $76.48.

Large investors have recently bought and sold shares of the company. BlackRock Inc. increased its stake in CVS Health by 22.0% in the 4th quarter. BlackRock Inc. now owns 92,954,958 shares of the pharmacy operator’s stock worth $6,090,409,000 after buying an additional 16,757,941 shares in the last quarter. Vanguard Group Inc increased its stake in CVS Health by 1.7% in the 3rd quarter. Vanguard Group Inc now owns 84,873,814 shares of the pharmacy operator’s stock worth $6,681,267,000 after buying an additional 1,445,887 shares in the last quarter. FMR LLC increased its stake in CVS Health by 30.6% in the 4th quarter. FMR LLC now owns 39,263,265 shares of the pharmacy operator’s stock worth $2,572,528,000 after buying an additional 9,194,005 shares in the last quarter. Wellington Management Group LLP increased its stake in CVS Health by 12.5% in the 1st quarter. Wellington Management Group LLP now owns 33,254,317 shares of the pharmacy operator’s stock worth $1,793,406,000 after buying an additional 3,696,854 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund increased its stake in CVS Health by 6,858.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 25,089,377 shares of the pharmacy operator’s stock worth $383,000 after buying an additional 24,728,818 shares in the last quarter. Hedge funds and other institutional investors own 77.48% of the company’s stock.

Shares of NYSE CVS traded down $0.64 during midday trading on Friday, hitting $53.33. 290,787 shares of the stock traded hands, compared to its average volume of 12,445,095. The stock has a market capitalization of $70.05 billion, a price-to-earnings ratio of 7.55, a PEG ratio of 1.09 and a beta of 0.88. The company has a debt-to-equity ratio of 1.45, a current ratio of 0.95 and a quick ratio of 0.64. CVS Health has a one year low of $51.72 and a one year high of $82.15.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Read More: What is the Coverage Ratio?

Get a free copy of the Zacks research report on CVS Health (CVS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.